![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 487/04 | (2006.01) |
A61K 31/519 | (2006.01) | ||
A61P 9/10 | (2006.01) |
(11) | Number of the document | 1824855 |
(13) | Kind of document | T |
(96) | European patent application number | 05812036.1 |
Date of filing the European patent application | 2005-12-05 | |
(97) | Date of publication of the European application | 2007-08-29 |
(45) | Date of publication and mention of the grant of the patent | 2012-08-08 |
(46) | Date of publication of the claims translation | 2012-11-24 |
(86) | Number | PCT/SE2005/001835 |
Date | 2005-12-05 |
(87) | Number | WO 2006/062465 |
Date | 2006-06-15 |
(30) | Number | Date | Country code |
0402972 | 2004-12-06 | SE | |
0501093 | 2005-05-13 | SE |
(72) |
BÖGEVIG, Anders, SE
LO-ALFREDSSON, Yvonne, SE
PIVONKA, Donald, US
TIDÉN, Anna-Karin, SE
|
(73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
(74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
(54) | Nauji pirolo[3, 2-d]pirimidin-4-ono dariniai ir jų panaudojimas |
Novel pyrrolo [3, 2-d]pyrimidin-4-one derivatives and their use in therapy |
Payment date | Validity (years) | Amount | |
2015-11-18 | 11 | 289.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2016-12-05 |